International Clinical Trial: The efficacy and tolerability of a moisturizer containing 5% Epigallocatechin-3-Gallate and 2% L-carnitine as adjunctive therapy for acne treatment

Geneva, June 8 -- International Clinical Trials Registry received information related to the study (TCTR20260531001) titled 'The efficacy and tolerability of a moisturizer containing 5% Epigallocatechin-3-Gallate and 2% L-carnitine as adjunctive therapy for acne treatment' on May 31.

Study Type: Interventional

Study Design: Randomized

Primary Sponsor: Prof. Montree Udompataikul

Condition: Mild-to-moderate acne vulgaris patients aged 18-40 years acne, skin tolerability, EGCG, L-carnitine, moisturizer, adapalene acne, skin tolerability, EGCG, L-carnitine, moisturizer, adapalene

Intervention: Active group: Moisturizer containing 5% epigallocatechin gallate (EGCG) and 2% L-carnitine (LC) with 5% dimethicone and glycerin with topical...